PanINSULA

N/A

Report date: 2025/03/20 09:13:54

Base Information

Drug NamePanINSULA
Drug Alias Nameallogeneic human pluripotent stem cell therapy (PanCryos)human pluripotent stem cell-derived glucose-responsive beta cells (PanCryos)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Pancreatic stem cell therapy
Mechanisms of ActionStem cells stimulants
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIt University Of Copenhagen
China Registration ClassN/A

Develop Information

Active CompaniesPanCryos
Inactive CompaniesIt University Of Copenhagen
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A